Software Daily Summary
Software Daily Summary: What Happened on October 22, 2026
Curated biology facts cut flagged errors in a small-model test
OpenBind is testing protein-binding predictions against 400 compounds, while Syneos executive Rajneesh Patil argues for connecting AI across clinical operations.
Today in brief
A curated table of biological facts reduced flagged reports in a test of MedGemma 4B, though the assessment had important limits.1 OpenBind launched a challenge to predict how 400 compounds bind to a Zika virus protease.2
Syneos Health executive Rajneesh Patil said linking AI systems could help clinical teams respond to trial risks sooner, with human review and accountability in place.3
Curated facts reduced flagged reports in a small-model test
A blinded assessment found four biology errors in reports from a distilled MedGemma 4B model and three from the base model.1 In one comparison, adding a curated ligand–receptor table cut flagged reports from six of 31 to zero.1 The author cautioned that the checker was adjusted after outputs were examined.1
OpenBind challenge tests Zika protease predictions
The blind challenge asks participants to predict protein–ligand complexes for 400 compounds against the Zika virus NS2B-NS3 protease.2 Organizers aim to assess where prediction methods work and fail.2
Patil calls for connected AI in clinical operations
Rajneesh Patil said contract research organizations should coordinate connected AI systems across clinical operations.3 He argued that teams should make clear what the AI influenced, who reviewed it, and how they resolved concerns.3
Also published
- What Expanding AI Ecosystems Mean for Sponsor Complexity and Oversight Applied Clinical Trials